Tirzepatide (Mounjaro®) is a new treatment option for managing obesity.
If you are eligible for tirzepatide on the NHS, we will contact you. You do not need to contact the surgery.
Some people living with obesity may be eligible to access tirzepatide for weight loss purposes in community settings as outlined in NICE guidelines. The treatment is prioritised for those with the greatest clinical need.
Please click the following link for more information and frequently asked questions: NHS_Tirzepatide_patient_FAQs